Literature DB >> 23061906

Inhibition of progression of androgen-dependent prostate LNCaP tumors to androgen independence in SCID mice by oral caffeine and voluntary exercise.

Xi Zheng1, Xiao-Xing Cui, Mou-Tuan Huang, Yue Liu, George C Wagner, Yong Lin, Weichung Joe Shih, Mao-Jung Lee, Chung S Yang, Allan H Conney.   

Abstract

The effect of oral caffeine or voluntary running wheel exercise (RW) alone or in combination on the progression of human androgen-dependent LNCaP prostate tumors to androgen independence in male severe combined immunodeficiency mice was determined. The mice were injected subcutaneously with LNCaP cells, and when the tumors reached a moderate size, the mice were surgically castrated and treated with caffeine (0.40 mg/ml drinking water) or RW alone or in combination for 42 days. We found that caffeine administration or RW inhibited the progression and growth of androgen-dependent LNCaP tumors to androgen independence, and a combination of the 2 regimens was more effective than the individual regimens alone. The ratios of the percent mitotic cells/caspase-3 positive cells in tumors from the caffeine-treated, RW-treated, or combination-treated mice were decreased by 34%, 38%, and 52%, respectively. Caffeine treatment increased the percentage of mitotic tumor cells undergoing apoptosis (lethal mitosis) whereas RW inhibited the increase in interleukin-6 that occurred during the progression of LNCaP tumors from androgen dependence to androgen independence. Our results indicate that oral administration of caffeine in combination with voluntary exercise may be an effective strategy for the prevention of prostate cancer progression from androgen dependence to androgen independence.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23061906     DOI: 10.1080/01635581.2012.716899

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  14 in total

1.  Physical Activity and Prostate Tumor Vessel Morphology: Data from the Health Professionals Follow-up Study.

Authors:  Erin L Van Blarigan; John P Gerstenberger; June M Chan; Lorelei A Mucci; Stacey A Kenfield; Edward L Giovannucci; Meir J Stampfer; Lee W Jones; Steven K Clinton
Journal:  Cancer Prev Res (Phila)       Date:  2015-08-14

2.  Atorvastatin and Caffeine in Combination Regulates Apoptosis, Migration, Invasion and Tumorspheres of Prostate Cancer Cells.

Authors:  Zhenshi Wang; Lanyue Zhang; Zheng Wan; Yan He; Huarong Huang; Hongping Xiang; Xiaofeng Wu; Kun Zhang; Yang Liu; Susan Goodin; Zhiyun Du; Xi Zheng
Journal:  Pathol Oncol Res       Date:  2018-05-24       Impact factor: 3.201

3.  Reduced signaling of PI3K-Akt and RAS-MAPK pathways is the key target for weight-loss-induced cancer prevention by dietary calorie restriction and/or physical activity.

Authors:  Joseph Standard; Yu Jiang; Miao Yu; Xiaoyu Su; Zhihui Zhao; Jianteng Xu; Jie Chen; Brenee King; Lizhi Lu; John Tomich; Richard Baybutt; Weiqun Wang
Journal:  J Nutr Biochem       Date:  2014-09-22       Impact factor: 6.048

Review 4.  Exercise in Regulation of Inflammation-Immune Axis Function in Cancer Initiation and Progression.

Authors:  Graeme J Koelwyn; Erik Wennerberg; Sandra Demaria; Lee W Jones
Journal:  Oncology (Williston Park)       Date:  2015-12       Impact factor: 2.990

5.  Modulation of blood flow, hypoxia, and vascular function in orthotopic prostate tumors during exercise.

Authors:  Danielle J McCullough; John N Stabley; Dietmar W Siemann; Bradley J Behnke
Journal:  J Natl Cancer Inst       Date:  2014-03-13       Impact factor: 13.506

6.  Association of BID SNPs (rs8190315 and rs2072392) and clinical features of benign prostate hyperplasia in Korean population.

Authors:  Hosik Seok; Su Kang Kim; Koo Han Yoo; Byung-Cheol Lee; Young Ock Kim; Joo-Ho Chung
Journal:  J Exerc Rehabil       Date:  2014-12-31

7.  Exercise and cancer: a position statement from the Spanish Society of Medical Oncology.

Authors:  M Pollán; S Casla-Barrio; J Alfaro; C Esteban; M A Segui-Palmer; A Lucia; M Martín
Journal:  Clin Transl Oncol       Date:  2020-02-13       Impact factor: 3.405

8.  Influence of a six month endurance exercise program on the immune function of prostate cancer patients undergoing Antiandrogen- or Chemotherapy: design and rationale of the ProImmun study.

Authors:  Philipp Zimmer; Elke Jäger; Wilhelm Bloch; Eva Maria Zopf; Freerk T Baumann
Journal:  BMC Cancer       Date:  2013-06-03       Impact factor: 4.430

9.  Inhibition of IL-6 expression in LNCaP prostate cancer cells by a combination of atorvastatin and celecoxib.

Authors:  Huaqian Wang; Xiao-Xing Cui; Susan Goodin; Ning Ding; Jeremiah Van Doren; Zhiyun Du; Mou-Tuan Huang; Yue Liu; Xiaodong Cheng; Robert S Dipaola; Allan H Conney; Xi Zheng
Journal:  Oncol Rep       Date:  2013-11-29       Impact factor: 3.906

10.  Stretching Reduces Tumor Growth in a Mouse Breast Cancer Model.

Authors:  L Berrueta; J Bergholz; D Munoz; I Muskaj; G J Badger; A Shukla; H J Kim; J J Zhao; H M Langevin
Journal:  Sci Rep       Date:  2018-05-18       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.